(Q38268840)

English

Pretreatment with P2Y12 inhibitors in non-ST-segment-elevation acute coronary syndrome is clinically justified.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

review article

1 reference

stated in

Europe PubMed Central

title

Pretreatment with P2Y12 inhibitors in non-ST-segment-elevation acute coronary syndrome is clinically justified (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

main subject

acute coronary syndrome

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

author name string

Marco Valgimigli

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

retrieved

1 September 2017

language of work or name

English

0 references

publication date

1 November 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

volume

130

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

issue

21

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

page(s)

1891-903; discussion 1903

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

Identifiers

DOI

10.1161/CIRCULATIONAHA.114.011319

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 February 2020

PubMed publication ID

25403595

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25403595

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25403595%20AND%20SRC:MED&resulttype=core&format=json

(Q38268840)

Pretreatment with P2Y12 inhibitors in non-ST-segment-elevation acute coronary syndrome is clinically justified.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)